Pursuing a Career in Clinical Research: When, Why, and How. Sergio Leonardi, MD, MHS Italian Cardiovascular Fellow.

Slides:

Advertisements

Similar presentations

Reversing Atherosclerosis with Aggressive Lipid Lowering Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association.

Advertisements

Standard Medical Therapy TRA 40 mg mg/d TRA 40 mg mg/d Placebo EP:CV Death/MI/stroke/hosp for RI/urgent coronary revasc. 1  EP:CV Death/MI/stroke/hosp.

Keith A A Fox Royal Infirmary & University of Edinburgh CURE and PCI-CURE.

Stanford ACS Guidelines 2003 David P. Lee, M.D. John S. Schroeder, M.D. *Donald Schreiber, M.D. Division of Cardiovascular Medicine and *Department of.

TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.

Bringing Together Training Programs, Title V, and Families for Leadership Development University of North Carolina MCH Leadership Consortium Kathleen Rounds.

UNC Biostatistics Michael R. Kosorok, Ph.D. Department of Biostatistics Department of Biostatistics The University of North Carolina at Chapel Hill.

Faculty Salary Equity Study University of North Carolina at Chapel Hill Faculty Council Report November 1, 2002.

Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.

Why the North of England and Why Leeds Sue Hunter International Office University of Leeds.

WHI Extension New Directions for Environmental Studies in the Women’s Health Initiative Annual WHI Investigator Meeting Washington, DC Friday.

Randomized Comparison of High-Dose Oral Vitamins versus Placebo in the Trial to Assess Chelation Therapy (TACT) Gervasio A. Lamas, MD, FACC Professor of.

Mark Your Calendar, Reserve Your Seat and Tell Your Colleagues: The CVRN Board Certification Review Course is Coming to: Come for the Best Review of Clinical.

Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.

Clopidogrel in ACS: Overview Investigator, TIMI Study Group Associate Physician, Cardiovascular Division, BWH Assistant Professor of Medicine, Harvard.

1 John Hopkins University (Baltimore, Maryland) 2 Georgia Institute of Technology (Atlanta, Georgia) 3 Duke University (Durham, North Carolina) 4 University.

Kenneth W. Mahaffey, Zhen Huang, Pierluigi Tricoci, Frans Van de Werf, Harvey D. White, Paul W. Armstrong, Claes Held, Sergio Leonardi, Philip E. Aylward,

Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.

Factors influencing treatment decisions for coronary artery disease after cardiac catheterization American Heart Association November 18, 2013 Dallas,

Presented December 5-6, 2015 by: Presented by: American College of Cardiovascular Nurses, American Board of Cardiovascular Medicine, and the NCH Healthcare.

For more info visit at For more info visit at

Assessing A-HeFT and PEACE Eric J Topol MD Provost and Chief Academic Officer Chair, Department of Cardiovascular Medicine Cleveland Clinic Foundation.

division_conferences_and_institu-0

Fenofibrate Intervention and Event Lowering in Diabetes FIELDFIELD Presented at The American Heart Association Scientific Sessions, November 2005 Presented.

North Shore Medical Clinic Clinic Services. Our Mission At North Shore Medical Center, our mission is to provide timely, compassionate, and high- quality.

Sustained Treatment as Prevention: Unprotected sex and increases in virological suppression after HAART initiation among participants in HPTN K.H.

Conclusions: Motivational interviews performed by a trained and specialized nurse staff and ambulatory cardiologic checks in ACS patients improved compliance.

CI-1 Ranexa™ (ranolazine) Extended Release Tablets Michael Sweeney, MD, FRCP VP, Medical Affairs CV Therapeutics, Inc. Cardiovascular and Renal Drugs Advisory.

University Medical Center School of Medicine Recognized world-wide as a leader in the education of health professionals.

John H. Alexander, MD, MHS Associate Professor of Medicine Director, Cardiovascular Research Duke Clinical Research Institute Duke Medicine Update on antithrombotics.

Next Steps Jill Healy, MS Ruth Gubernick, MPH Florida Pediatric Medical Home Demonstration Project (C4K) Learning Session September 23-24, 2011.

Cardiovascular Risk and NSAIDs Arthritis Advisory Committee Meeting November 29, 2006 Sharon Hertz, M.D. Deputy Director Division of Analgesia, Anesthesia,

Vorapaxar for Secondary Prevention in Patients with Prior Myocardial Infarction Benjamin M. Scirica, MD, MPH On behalf of the TRA 2°P-TIMI 50 Steering.

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 ARBITER-2 Trial Presented at The American Heart Association Scientific.

UNC school By: Weston wall. history 1.The University of North Carolina at Chapel Hill is the nation's oldest state university, with a rich history of.

Quality Healthcare Includes You! Volunteer Opportunities at University Medical Center.

Clinical Trial Results. org METEOR Trial Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. John R.

NSTE Acute Coronary Syndromes

Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.

Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.

Good things are happening in Durham! The Denson Apartments Supportive Housing for Homeless Veterans Durham is the 4 th largest city in North Carolina.

European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.

Rosuvastatin 10 mg n=2514 Placebo n= to 4 weeks Randomization 6weeks3 monthly Closing date 20 May 2007 Eligibility Optimal HF treatment instituted.

Houston, TX June 25-26, 2016 Brought to you by: American College of Cardiovascular Nurses, American Board of Cardiovascular Medicine, and Memorial Hermann.

NCAA & Agriculture EQ: What top commodities do other states have in comparison to NC?

August 27-28, 2016 Denver, CO Presented by: American College of Cardiovascular Nurses, American Board of Cardiovascular Medicine, and the Rose Medical.

Presentation Title R3 이지영 / 김 수 중교 수 님. Introduction Lowering LDL cholesterol levels with statins : Reduce the risk of cardiovascular disease Vascular.

Regional Anesthesia and Acute Pain Medicine Fellowship University of California, San Diego.

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Varespladib and Cardiovascular Events in Patients.

Cardiovascular Nursing Review Course & Board Certification Opportunity

3 Rd Year General Cardiology Fellows Medical University of South Carolina.

1 st Year General Cardiology Fellows Medical University of South Carolina.

Cape Fear HealthNet: How Physicians can help March 2010

The role of unknown risk factors in coronary heart disease

Baseline characteristics and effectiveness results

University of North Carolina Department of Pediatrics Faculty Meeting

Impact of regionalization of ST elevation myocardial infarction care on treatment times and outcomes for emergency medical services transported patients.

CSS Clinical Trial Launched: January 2018

EMPHASIS-HF Extended Follow-up

SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.

St. Luke’s Miners Hospital, USA

What oral antiplatelet therapy would you choose?

FBYFL Injury Clinic Designed for the athletes of FBYFL who have sustained a sports injury during practice or games and would a complimentary evaluation.

Refurbishing Mayo Clinic Proceedings:

Fall 2018, COMP 562 Poster Session

MACE: Death, MI or TLR at 5 years

Effects of Niacin on Glucose Control in Patients With Dyslipidemia

W5 is nestled here in the Research Triangle region of North Carolina, comprised of Raleigh,

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

Section C: Clinical trial update: Oral antiplatelet therapy

Presentation transcript:

Pursuing a Career in Clinical Research: When, Why, and How. Sergio Leonardi, MD, MHS Italian Cardiovascular Fellow

All Rights Reserved, Duke Medicine 2007 DUKE University One of the most prestigious Universities of the United States Duke Heart Center consistently ranked among the top 10 heart centers in the United States in the last 10 years

All Rights Reserved, Duke Medicine 2007 DUKE in Durham, North Carolina The Chapel, symbol of Duke Durham, NC

All Rights Reserved, Duke Medicine 2007 North Pavilion 846 Faculty and Staff Durham Centre 288 Faculty and Staff Hock Plaza Statistical Faculty 5

All Rights Reserved, Duke Medicine 2007 Standard Medical Therapy Vorapaxar 40 mg mg/d Placebo 1  EP:CV Death/MI/stroke/hosp for RI/urgent coronary revasc 2  EP: CV Death/MI/stroke Double-blind Non-ST-Segment Elevation ACS N=12,500 Follow-Up Day 30; 4, 8, 12 Months; Every 6 months after 1st year Final Visit 1:1

All Rights Reserved, Duke Medicine 2007 Orlando, FL LBCT Session Sunday November 13 th 2011 h

All Rights Reserved, Duke Medicine 2007 Contact Info Sergio Leonardi